{"id":1053,"date":"2023-10-20T10:50:32","date_gmt":"2023-10-20T10:50:32","guid":{"rendered":"https:\/\/genomefrontier.com\/?post_type=portfolio&#038;p=1053"},"modified":"2026-04-13T08:06:26","modified_gmt":"2026-04-13T08:06:26","slug":"news025","status":"publish","type":"portfolio","link":"https:\/\/genomefrontier.com\/zh\/portfolio-item\/news025\/","title":{"rendered":"\u5148\u9a45\u751f\u6280\u8207\u6fb3\u6d32\u7684BioCina\u5efa\u7acb\u7b56\u7565\u5408\u4f5c\u5925\u4f34\u95dc\u4fc2\uff0c\u5171\u540c\u958b\u767c\u8207\u88fd\u9020GF-CART01\u7d30\u80de\u6cbb\u7642\u7522\u54c1\u6240\u9700\u4e4bDNA\u539f\u6599\u3002"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"menu_order":0,"comment_status":"open","ping_status":"closed","template":"","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":""},"portfolio-types":[],"class_list":["post-1053","portfolio","type-portfolio","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GenomeFrontier Partners with BioCina for the Development and Manufacturing of GF-CART01 Cell Therapy Product DNA Materials. - GenomeFrontier Therapeutics, Inc. \u5148\u9a45\u751f\u6280<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genomefrontier.com\/zh\/portfolio-item\/news025\/\" \/>\n<meta property=\"og:locale\" content=\"zh_TW\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GenomeFrontier Partners with BioCina for the Development and Manufacturing of GF-CART01 Cell Therapy Product DNA Materials. - GenomeFrontier Therapeutics, Inc. \u5148\u9a45\u751f\u6280\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genomefrontier.com\/zh\/portfolio-item\/news025\/\" \/>\n<meta property=\"og:site_name\" content=\"GenomeFrontier Therapeutics, Inc. \u5148\u9a45\u751f\u6280\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-13T08:06:26+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/genomefrontier.com\\\/portfolio-item\\\/news025\\\/\",\"url\":\"https:\\\/\\\/genomefrontier.com\\\/portfolio-item\\\/news025\\\/\",\"name\":\"GenomeFrontier Partners with BioCina for the Development and Manufacturing of GF-CART01 Cell Therapy Product DNA Materials. - GenomeFrontier Therapeutics, Inc. \u5148\u9a45\u751f\u6280\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/genomefrontier.com\\\/#website\"},\"datePublished\":\"2023-10-20T10:50:32+00:00\",\"dateModified\":\"2026-04-13T08:06:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/genomefrontier.com\\\/portfolio-item\\\/news025\\\/#breadcrumb\"},\"inLanguage\":\"zh-TW\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/genomefrontier.com\\\/portfolio-item\\\/news025\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/genomefrontier.com\\\/portfolio-item\\\/news025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/genomefrontier.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GenomeFrontier Partners with BioCina for the Development and Manufacturing of GF-CART01 Cell Therapy Product DNA Materials.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/genomefrontier.com\\\/#website\",\"url\":\"https:\\\/\\\/genomefrontier.com\\\/\",\"name\":\"GenomeFrontier Therapeutics, Inc. \u5148\u9a45\u751f\u6280\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/genomefrontier.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-TW\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GenomeFrontier Partners with BioCina for the Development and Manufacturing of GF-CART01 Cell Therapy Product DNA Materials. - GenomeFrontier Therapeutics, Inc. \u5148\u9a45\u751f\u6280","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genomefrontier.com\/zh\/portfolio-item\/news025\/","og_locale":"zh_TW","og_type":"article","og_title":"GenomeFrontier Partners with BioCina for the Development and Manufacturing of GF-CART01 Cell Therapy Product DNA Materials. - GenomeFrontier Therapeutics, Inc. \u5148\u9a45\u751f\u6280","og_url":"https:\/\/genomefrontier.com\/zh\/portfolio-item\/news025\/","og_site_name":"GenomeFrontier Therapeutics, Inc. \u5148\u9a45\u751f\u6280","article_modified_time":"2026-04-13T08:06:26+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/genomefrontier.com\/portfolio-item\/news025\/","url":"https:\/\/genomefrontier.com\/portfolio-item\/news025\/","name":"GenomeFrontier Partners with BioCina for the Development and Manufacturing of GF-CART01 Cell Therapy Product DNA Materials. - GenomeFrontier Therapeutics, Inc. \u5148\u9a45\u751f\u6280","isPartOf":{"@id":"https:\/\/genomefrontier.com\/#website"},"datePublished":"2023-10-20T10:50:32+00:00","dateModified":"2026-04-13T08:06:26+00:00","breadcrumb":{"@id":"https:\/\/genomefrontier.com\/portfolio-item\/news025\/#breadcrumb"},"inLanguage":"zh-TW","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genomefrontier.com\/portfolio-item\/news025\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/genomefrontier.com\/portfolio-item\/news025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/genomefrontier.com\/"},{"@type":"ListItem","position":2,"name":"GenomeFrontier Partners with BioCina for the Development and Manufacturing of GF-CART01 Cell Therapy Product DNA Materials."}]},{"@type":"WebSite","@id":"https:\/\/genomefrontier.com\/#website","url":"https:\/\/genomefrontier.com\/","name":"GenomeFrontier Therapeutics, Inc. \u5148\u9a45\u751f\u6280","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genomefrontier.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-TW"}]}},"_links":{"self":[{"href":"https:\/\/genomefrontier.com\/zh\/wp-json\/wp\/v2\/portfolio\/1053","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genomefrontier.com\/zh\/wp-json\/wp\/v2\/portfolio"}],"about":[{"href":"https:\/\/genomefrontier.com\/zh\/wp-json\/wp\/v2\/types\/portfolio"}],"author":[{"embeddable":true,"href":"https:\/\/genomefrontier.com\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/genomefrontier.com\/zh\/wp-json\/wp\/v2\/comments?post=1053"}],"wp:attachment":[{"href":"https:\/\/genomefrontier.com\/zh\/wp-json\/wp\/v2\/media?parent=1053"}],"wp:term":[{"taxonomy":"portfolio-types","embeddable":true,"href":"https:\/\/genomefrontier.com\/zh\/wp-json\/wp\/v2\/portfolio-types?post=1053"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}